Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
For skin-specific concerns, it is best to consult a healthcare provider or dermatologist to determine the appropriate treatment
A chaotic, disorganized workspace is a recipe for error
Journal of the National Comprehensive Cancer Network, 7(1), 78-84
Prior to 2021, white patients represented greater than 70 percent of trial participants over at least 5 years in the areas of analgesia/anesthesiology/anti-inflammatory, cardiovascular disease, endocrinology/metabolism/bone, infectious disease (nonviral), oncology, ophthalmology, and pulmonary
Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer
MTSL caused peak broadening near the labeled residues, allowing us to identify which region of the FOXO4 FHD was close to the p53 TAD
US$ 24.06
US$ 22.05
US$ 22.83
US$ 26.65
US$ 29.46
US$ 20.57
US$ 20.38
US$ 22.06
US$ 27.84
US$ 28.44
